Adiponectin, an insulin-sensitizing adipokine, consistently shows decreased levels in first- and second-trimester GDM patients, with studies reporting an area under the curve (AUC) of 0.634–0.801 for its predictive ability [51,52,53,54,55]. Here, ADIPOQ is linked to gestational diabetes.